T. Lash, and S. Cole. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 (23):
e55-6(August 2009)5436<m:linebreak></m:linebreak>JID: 8309333; 2009/07/13 aheadofprint; ppublish;<m:linebreak></m:linebreak>Mesures d'associació; Immortal time bias.
L. Chen, M. Yen, H. Wu, C. Liao, D. Liou, H. Kuo, and T. Chen. Journal of evaluation in clinical practice, 11 (2):
181-93(April 2005)3816<m:linebreak></m:linebreak>Anàlisi de supervivència; SAS.
S. Lagakos. The New England journal of medicine, 355 (2):
113-7(July 2006)4860<m:linebreak></m:linebreak>LR: 20071115; JID: 0255562; 0 (Cyclooxygenase 2 Inhibitors); 0 (Lactones); 0 (Sulfones); 0 (rofecoxib); CON: N Engl J Med. 2005 Mar 17;352(11):1092-102. PMID: 15713943; 2006/06/26 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència.
J. Lindsey, and L. Ryan. Statistics in medicine, 17 (2):
219-38(January 1998)2874<m:linebreak></m:linebreak>Tutorial in Biostatistics;<m:linebreak></m:linebreak>Anàlisi de supervivència; Interval-censored.